These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 685993)

  • 1. Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart.
    Kirk ES; LeJemtel TH; Nelson GR; Sonnenblick EH
    Am J Med; 1978 Jul; 65(1):189-96. PubMed ID: 685993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.
    Verdouw PD; Hartog JM; Duncker DJ; Roth W; Saxena PR
    Eur J Pharmacol; 1986 Jul; 126(1-2):21-30. PubMed ID: 2875884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
    Yamamoto K; Masuyama T; Nagano R; Doi Y; Naito J; Mano T; Kondo H; Hori M; Kamada T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):596-602. PubMed ID: 8569221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vasodilators upon function and metabolism of ischemic myocardium.
    da Luz PL; Forrester JS
    Am J Cardiol; 1976 Mar; 37(4):581-7. PubMed ID: 1258795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
    Greenberg S; Touhey B; Paul J
    Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function.
    Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperosmotic mannitol on myocardial oxygen consumption.
    Vlahakes GJ; Powell WJ
    Am J Physiol; 1977 Oct; 233(4):H444-50. PubMed ID: 303055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;
    Luz PL; Forrester JS; Wyatt HL; Tyberg JV; Chagrasulis R; Parmley WW; Swan HJ
    Circulation; 1975 Sep; 52(3):400-7. PubMed ID: 1157236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of insulin and beta receptor blockade during acute left ventricular failure in dogs.
    Reikerås O; Gunnes P; Sørlie D; Ekroth R; Mjøs OD
    Eur Heart J; 1986 Mar; 7(3):227-33. PubMed ID: 3519226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts.
    Miller RR; Palomo AR; Brandon TA; Hartley CJ; Quinones MA
    Am Heart J; 1981 Sep; 102(3 Pt 2):500-8. PubMed ID: 7023220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroglycerin and propranolol on myocardial O2 consumption during myocardial ischemia.
    Daniell HB
    Eur J Pharmacol; 1977 Mar; 42(1):79-84. PubMed ID: 403076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of digitalis on the normal and the failing heart.
    Braunwald E
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):51A-59A. PubMed ID: 3886752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.